Market Overview:
The global iohexol injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of renal diseases, rising demand for minimally invasive surgeries, and technological advancements in the field of medical imaging. By type, the 350mg I/ml segment is expected to account for the largest share of the global iohexol injection market in 2018. By application, hospitals are expected to account for the largest share of this market in 2018.
Product Definition:
Iohexol injection is a contrast agent used in medical imaging. It is used to improve the visibility of certain tissues or organs in images taken using X-rays, CT scans, or MRIs. Iohexol injection helps to highlight these tissues by making them appear darker than surrounding tissue on images. This can help doctors better visualize abnormalities and diagnose diseases.
350mg I/ml:
350mg I/ml is a special kind of intravenous solution containing 350 mg/mcl of sodium chloride. It's used for the treatment of cardiac arrest and it helps to keep blood fluid levels normal. The increasing prevalence rate of cardiovascular diseases, such as coronary artery disease, heart attack, and hypertension are expected to boost demand for this drug in the coming years.
240mg I/ml:
240mg I/ml is the concentration of Iohexol in 1 ml solution. It is used as a blood thinner and it helps to prevent blood clots from forming. The drug has different brands under which various drugs are available such as Corifact, Kogenate, and Kerlix among others.
Application Insights:
The hospitals application segment dominated the global market in 2017. Hospitals are majorly concentrated in developed regions with a higher cost of living, which has led to an increase in demand for expensive pharmaceutical products that are proven to work. Iohexol is one of these pharmaceutical products as it is used for various medical conditions such as kidney failure, heart attack and stroke among others. It helps reduce swelling and prevent complications associated with them by increasing blood flow & reducing inflammation. These factors have resulted in the hospitals application segment being the largest revenue generating segment over the forecast period among other applications including clinics and pharmacies.
Iohexol injections can also be used during surgery as they help reduce postoperative pain by decreasing inflammation at a cellular level without causing any damage to surrounding tissues or organs due to its non-toxic nature at high doses (250mg/ml).
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, high disposable income and favorable reimbursement policies are some of the major factors responsible for its large share. Moreover, increasing government initiatives to promote advanced medical treatments is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising geriatric population and prevalence of chronic diseases in developing countries such as China and India. Growing medical tourism industry due to low treatment cost coupled with improving healthcare infrastructure will boost demand for iohexol injections in this region over the next eight years.
Growth Factors:
- Increasing incidence of chronic kidney diseases (CKD) and rising demand for effective diagnostic procedures and treatments
- Growing number of aging population and increasing prevalence of age-related renal disorders
- Technological advancements in the field of renal diagnostics and treatment options
- Rising healthcare expenditure by governments, private players, and individuals to support better diagnosis and treatment for CKD patients
- Availability of funding from public-private partnerships to promote research on novel therapies for treating CKD
Scope Of The Report
Report Attributes
Report Details
Report Title
Iohexol Injection Market Research Report
By Type
350mg I/ml, 240mg I/ml, 300mg I/ml, Others
By Application
Hospitals, Clinics
By Companies
GE Healthcare, Imax, Grupo Juste, Daiichi Sankyo, Takeda, Fuji Pharma, Towaseiyaku, Hikari Pharmaceutical, YRPG, BeiLu Pharma, GE Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
183
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Iohexol Injection Market Report Segments:
The global Iohexol Injection market is segmented on the basis of:
Types
350mg I/ml, 240mg I/ml, 300mg I/ml, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Imax
- Grupo Juste
- Daiichi Sankyo
- Takeda
- Fuji Pharma
- Towaseiyaku
- Hikari Pharmaceutical
- YRPG
- BeiLu Pharma
- GE Healthcare
Highlights of The Iohexol Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 350mg I/ml
- 240mg I/ml
- 300mg I/ml
- Others
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Iohexol Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Iohexol injection is a medication used to stop or prevent bleeding. It is given as an intravenous (into the vein) injection.
Some of the key players operating in the iohexol injection market are GE Healthcare, Imax, Grupo Juste, Daiichi Sankyo, Takeda, Fuji Pharma, Towaseiyaku, Hikari Pharmaceutical, YRPG, BeiLu Pharma, GE Healthcare.
The iohexol injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Iohexol Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Iohexol Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Iohexol Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Iohexol Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Iohexol Injection Market Size & Forecast, 2018-2028
4.5.1 Iohexol Injection Market Size and Y-o-Y Growth
4.5.2 Iohexol Injection Market Absolute $ Opportunity
Chapter 5 Global Iohexol Injection Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Iohexol Injection Market Size Forecast by Type
5.2.1 350mg I/ml
5.2.2 240mg I/ml
5.2.3 300mg I/ml
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Iohexol Injection Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Iohexol Injection Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Iohexol Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Iohexol Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Iohexol Injection Analysis and Forecast
9.1 Introduction
9.2 North America Iohexol Injection Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Iohexol Injection Market Size Forecast by Type
9.6.1 350mg I/ml
9.6.2 240mg I/ml
9.6.3 300mg I/ml
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Iohexol Injection Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Iohexol Injection Analysis and Forecast
10.1 Introduction
10.2 Europe Iohexol Injection Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Iohexol Injection Market Size Forecast by Type
10.6.1 350mg I/ml
10.6.2 240mg I/ml
10.6.3 300mg I/ml
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Iohexol Injection Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Iohexol Injection Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Iohexol Injection Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Iohexol Injection Market Size Forecast by Type
11.6.1 350mg I/ml
11.6.2 240mg I/ml
11.6.3 300mg I/ml
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Iohexol Injection Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Iohexol Injection Analysis and Forecast
12.1 Introduction
12.2 Latin America Iohexol Injection Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Iohexol Injection Market Size Forecast by Type
12.6.1 350mg I/ml
12.6.2 240mg I/ml
12.6.3 300mg I/ml
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Iohexol Injection Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Iohexol Injection Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Iohexol Injection Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Iohexol Injection Market Size Forecast by Type
13.6.1 350mg I/ml
13.6.2 240mg I/ml
13.6.3 300mg I/ml
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Iohexol Injection Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Iohexol Injection Market: Competitive Dashboard
14.2 Global Iohexol Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE Healthcare
14.3.2 Imax
14.3.3 Grupo Juste
14.3.4 Daiichi Sankyo
14.3.5 Takeda
14.3.6 Fuji Pharma
14.3.7 Towaseiyaku
14.3.8 Hikari Pharmaceutical
14.3.9 YRPG
14.3.10 BeiLu Pharma
14.3.11 GE Healthcare
